CHERYL LAYFIELD: Open Payments
NPI 1033193479 · SELBYVILLE, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,146 in 39 payments from 17 companies in 2025. Trend: 2023 $2,315 · 2024 $2,192 · 2025 $3,146
Food & beverage: $3,146
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $780 |
| Amgen Inc. | 3 | $345 |
| Gilead Sciences, Inc. | 2 | $253 |
| Phathom Pharmaceuticals, Inc. | 2 | $247 |
| KYOWA KIRIN, INC. | 2 | $230 |
| Actelion Pharmaceuticals US, Inc. | 2 | $215 |
| Axsome Therapeutics, Inc. | 2 | $184 |
| PFIZER INC. | 3 | $171 |
| Novo Nordisk Inc | 3 | $154 |
| Xeris Pharmaceuticals, Inc. | 1 | $135 |
Products named: AIRSUPRA, KRYSTEXXA, FASENRA, VOQUEZNA, CRYSVITA, UPTRAVI, Ozempic, BREZTRI.
Industry payments across DE — which companies pay providers there.
